NCT03393247 is a NA clinical trial of infliximab and azathioprine combination at week 0 in Crohn Disease, sponsored by Sixth Affiliated Hospital, Sun Yat-sen University.

Who is sponsoring NCT03393247?

NCT03393247 is sponsored by Sixth Affiliated Hospital, Sun Yat-sen University.

What drugs are being tested in NCT03393247?

Interventions in NCT03393247: infliximab and azathioprine combination at week 0, infliximab and azathioprine combination at week 14.

What condition does NCT03393247 study?

NCT03393247 studies Crohn Disease.

Is NCT03393247 still recruiting?

NCT03393247 is currently status unknown. Last updated 8 January 2018.

Last reviewed 2018-01-08 · How we verify

NCT03393247

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Therapy Effect of Azathioprine Initial or 14 Weeks After Combined With Infliximab on CD

Status unknown NA Last updated 8 January 2018

What this trial tests

NA trial testing infliximab and azathioprine combination at week 0 in Crohn Disease in 160 participants. Status unknown.

Timeline

1 June 2017

Primary endpoint
1 July 2018

1 July 2019

Quick facts

Lead sponsor	Sixth Affiliated Hospital, Sun Yat-sen University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	160
Start date	1 June 2017
Primary completion	1 July 2018
Estimated completion	1 July 2019
Sites	1 location across China

Drugs / interventions tested

infliximab and azathioprine combination at week 0 — full drug profile →
infliximab and azathioprine combination at week 14 — full drug profile →

Conditions studied

Crohn Disease — all drugs for Crohn Disease →

Sponsor

Sixth Affiliated Hospital, Sun Yat-sen University

Who can join

Adults 14 to 60, any sex, with Crohn Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aim to identify the therapeutic effect of azathioprine during infliximab(IFX) treatment in Crohn's disease (CD).Half of patients will receive azathioprine and infliximab combination therapy at the same time. The other half patients will be given infliximab therapy first and then receive azathioprine 14 weeks later.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Infliximab for maintenance of medically-induced remission in Crohn's disease.
Gordon M, Sinopoulou V, Akobeng AK, Sarian A, et al · · 2024 · cited 4× · PMID 38372447 · DOI 10.1002/14651858.cd012609.pub2

Verify or expand the search:

Other recruiting trials for Crohn Disease

Currently open trials in the same condition.

NCT06953791 — Comparison of Quality of Life During a Flare of Crohn's Disease Treated With Prednisolone or aCDED With PEN in Adult Pat · Phase 2 · recruiting
NCT07310095 — A Study to Evaluate the Efficacy of Guselkumab in Chinese Participants With Crohn's Disease (CD) · Phase 4 · recruiting
NCT07364734 — Epidemiological Characteristics and Efficacy Evaluation of Difficult-To-Treat Crohn's Disease · recruiting
NCT07170462 — Cranberry and Gut Health in Crohn's Disease · EARLY_PHASE1 · recruiting
NCT07196722 — A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease · Phase 2, PHASE3 · recruiting

Other Sixth Affiliated Hospital, Sun Yat-sen University trials

Trials by the same sponsor.

NCT07538284 — MInimizing Delirium With Nasal Dexmedetomidine-InducEd Sleep (MIDDIES) · Phase 2, PHASE3 · not yet recruiting
NCT07176182 — Clinical Trial of Neoadjuvant mFOLFOX Plus Alvenor for LARC Patients With High YWHAB Expression · Phase 2 · not yet recruiting
NCT07510191 — TNFi Plus Low-Dose Upadacitinib vs TNFi Intensification in Crohn's Disease With Suboptimal Response · Phase 4 · recruiting
NCT07344428 — Efficacy and Safety of CDED With Anti-TNF-α Biologics in Crohn's Disease: A Randomized Trial · NA · not yet recruiting
NCT07328958 — Effect of Titrated Administration of Ciprofol on Perioperative Hypotension in Elderly Patients Undergoing Laparoscopic A · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03393247 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sixth Affiliated Hospital, Sun Yat-sen University
Last refreshed: 8 January 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03393247.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing